HR 3233, the Healthy Babies Act of 2025, amends the Child Nutrition Act to require the WIC program to add infant food combinations and dinners to its list of approved supplemental foods within one year of the bill's enactment. This change directly affects WIC participants, including low-income pregnant women, new mothers, and infants, by expanding the types of infant food available through the program. The key provision mandates the Secretary of Agriculture to update WIC regulations to include these specific food items, ensuring they meet nutritional standards. The bill does not create new funding but modifies existing program offerings under WIC.
S 2287, the Palliative Care and Hospice Education and Training Act, establishes federal funding to expand training for health professionals in palliative and hospice care. The bill creates multiple programs including grants for education programs, fellowships for faculty to gain specialized training, and career incentive awards for students pursuing palliative care specialties. It prioritizes training in rural and underserved areas, for pediatric populations, and for racial and ethnic minorities. The bill authorizes $15 million annually through 2030 to build a more skilled palliative care workforce for patients with serious or life-threatening illnesses.
This resolution supports recognizing March 14, 2026, as Black Midwives Day to honor the contributions of Black midwives to maternal and infant health. It highlights the importance of midwifery in addressing maternal health disparities and the maternity care desert crisis affecting millions of women. The resolution calls for federal and state governments to take actions such as increasing funding for midwifery education, removing regulatory barriers, and expanding insurance coverage for midwifely care. It also encourages efforts to decriminalize midwifery practices and promote culturally competent care to improve health outcomes for Black mothers and infants.
This resolution formally recognizes March 14, 2026, as Black Midwives Day to honor the contributions of Black midwives to maternal and infant health in the United States. It highlights the importance of midwifery in addressing gaps in healthcare access and reducing maternal mortality rates, which are disproportionately high among Black women. The bill encourages federal, state, and local governments to take actions such as diversifying the perinatal workforce, removing regulatory barriers for midwives, and expanding insurance coverage for midwifery services. It also calls for increased funding for education and mentorship programs to support Black midwives and promote culturally competent care.
The PLAY Act establishes a federal task force led by the Health and Human Services and Interior Departments to coordinate efforts improving access to safe, community-based play spaces for children under 18. The task force will identify barriers to playground access, develop recommendations for agencies to collaborate on child wellness infrastructure (like playgrounds and outdoor learning areas), and report findings to Congress within one year. It does not fund new playgrounds but focuses on interagency coordination and evidence-based strategies to promote physical activity and health through existing public lands and community spaces. This bill directly affects federal agencies with jurisdiction over public lands, parks, and community health programs.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
HR 87, the "Protecting Our Children from the CDC Act," requires the CDC to publicly post all clinical safety and effectiveness data for any COVID-19 vaccine before it can be added to the official child and adolescent immunization schedule. It automatically removes all currently listed COVID-19 vaccines from that schedule upon the bill's enactment. The bill mandates that all posted data must be de-identified to protect privacy. This applies specifically to the CDC's Advisory Committee on Immunization Practices (ACIP) schedule and affects how future CDC vaccine recommendations for children are made. The law does not alter the CDC's authority to later reinstate a vaccine if the required data is posted.
The Poverty Line Act of 2025 updates how the federal poverty line is calculated to better reflect current costs of basic needs. It requires annual revisions using a 5-year average of household spending on food, housing, childcare, and healthcare (adjusted for inflation), with regional variations based on state or county data. This change directly affects households applying for federal assistance programs like SNAP or Medicaid, as eligibility will now align with more accurate, location-specific costs. The bill also mandates a public online tool to help determine poverty line thresholds and includes safeguards to prevent sudden eligibility changes during relocations.
HR 6054, the Fairness to Kids with Cancer Act of 2025, requires federal cancer research funding to allocate pediatric research dollars proportionally based on the U.S. child population. Specifically, for fiscal years 2026 and beyond, the percentage of cancer research funds dedicated to pediatric cancer must match the ratio of children under 18 to the total U.S. population, as determined by the Census Bureau. This directly affects how federal cancer research dollars are distributed, ensuring pediatric cancer research receives funding aligned with the proportion of young patients. The bill mandates this calculation annually, shifting funding allocation toward pediatric research without specifying new programs or budget increases.
HR 2527, the Early Detection of Vision Impairments for Children Act of 2025, provides federal grants to states, territories, tribes, and urban Indian organizations to establish statewide vision screening and intervention programs for children. The bill requires grantees to implement vision screenings in medical, home, educational, and early learning settings, develop data systems for tracking outcomes, and improve access to care for underserved children in rural and low-income communities. It also authorizes technical assistance grants through the CDC to help develop screening systems, share best practices, and conduct research on vision care programs. The bill allocates $5 million annually for fiscal years 2026-2030 to fund these activities, targeting early detection to prevent vision-related learning and developmental challenges.
